Detalles de la búsqueda
1.
Safety and effectiveness of three novel all-oral shortened regimens for rifampicin- or multidrug-resistant tuberculosis in Kazakhstan.
Clin Infect Dis
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38833593
2.
Pregnancy and Birth Outcomes in Patients With Multidrug-Resistant Tuberculosis Treated With Regimens That Include New and Repurposed Drugs.
Clin Infect Dis
; 78(1): 144-148, 2024 01 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37606512
3.
Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis.
Int J Infect Dis
; 113 Suppl 1: S91-S95, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-33823277
4.
Corrigendum to 'Culture conversion at six months in patients receiving bedaquiline- and delamanid-containing regimens for the treatment of multidrug-resistant tuberculosis' International Journal of Infectious Diseases Volume 113S1 (2021) S91-S95.
Int J Infect Dis
; 121: 105, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35613479
Resultados
1 -
4
de 4
1
Próxima >
>>